Evidence map›Paper›PMID 39252309›Full record

ArticleMedicine2024

Construction of thyroid cancer classification and iodine metabolism related diagnostic model using thyroid differentiation score and bioinformation.

Qiu-Ying Zhang, Yan Wang, Qiang Zhang, Da-Wei Huo, Yue Li, De Gao, Pan-Pan Wang, Hai-Chao Yan

Abstract read
In one paragraph

Article in Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiu-Ying ZhangSurgical Oncology, The Fifth People's Hospital of Ningxia, Shizuishan, China.ORCID 0009-0001-4305-8064
Yan WangDepartment of Nephrology, Ningxia Medical University Generai Hospital, Yinchuan, China.
Qiang ZhangDepartment of Chinese Medicine, The Fifth People's Hospital of Ningxia, Shizuishan, China.
Da-Wei HuoSurgical Oncology, The Fifth People's Hospital of Ningxia, Shizuishan, China.
Yue LiSurgical Oncology, The Fifth People's Hospital of Ningxia, Shizuishan, China.
De GaoSurgical Oncology, The Fifth People's Hospital of Ningxia, Shizuishan, China.
Pan-Pan WangSurgical Oncology, The Fifth People's Hospital of Ningxia, Shizuishan, China.
Hai-Chao YanDepartment of Thyroid Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To more accurately diagnose and treat patients with different subtypes of thyroid cancer, we constructed a diagnostic model related to the iodine metabolism of THCA subtypes. THCA expression profiles, corresponding clinicopathological information, and single-cell RNA-seq were downloaded from TCGA and GEO databases. Genes related to thyroid differentiation score were obtained by GSVA. Through logistic analyses, the diagnostic model was finally constructed. DCA curve, ROC curve, machine learning, and K-M analysis were used to verify the accuracy of the model. qRT-PCR was used to verify the expression of hub genes in vitro. There were 104 crossover genes between different TDS and THCA subtypes. Finally, 5 genes (ABAT, CHEK1, GPX3, NME5, and PRKCQ) that could independently predict the TDS subpopulation were obtained, and a diagnostic model was constructed. ROC, DCA, and RCS curves exhibited that the model has accurate prediction ability. K-M and subgroup analysis results showed that low model scores were strongly associated with poor PFI in THCA patients. The model score was significantly negatively correlated with T cell follicular helper. In addition, the diagnostic model was significantly negatively correlated with immune scores. Finally, the results of qRT-PCR corresponded with bioinformatics results. This diagnostic model has good diagnostic and prognostic value for THCA patients, and can be used as an independent prognostic indicator for THCA patients.

Indexed as

IodineThyroid NeoplasmsBiomarkers, TumorCell DifferentiationComputational BiologyFemaleHumansMachine LearningMaleMiddle AgedROC CurveThyroid GlandBiomarkers, TumorIodine

Identifiers

PMID39252309
PMCPMC12431767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.